The incidence and prevalence of well-differentiated Bronchial NETs has been increasing globally in recent years. This may be due to better diagnostic/detection techniques and a greater awareness of these conditions. Despite this, these cancers are still uncommon and therefore most clinicians will not manage many of these patients. As a consequence, gaining experience in treating these cancers can become challenging. In the absence of a move to centralise their care, guidelines can play an invaluable role in helping clinicians manage these patients and standardise the diagnostic and treatment pathways nationally and internationally. The added benefit of national/global adherence to a single set of guidelines is that useful real world data can be extracted on effectiveness of various aspects of the guidelines where practice is uncertain due to brevity of data. The aim of this talk is to discuss the main parts of the most recently published ENETS Bronchial NETS Guidelines using case studies to highlight strengths and weaknesses in the guidelines and to update on recent developments in this field.
05 Dec 2016
UK and Ireland Neuroendocrine Tumour Society